DocSym
β
Searchsearch
Search
(C77.1) Secondary and unspecified malignant neoplasm: intrathoracic lymph nodes
More details coming soon
796 389 in individuals diagnosis secondary and unspecified malignant neoplasm: intrathoracic lymph nodes confirmed
38 714 deaths with diagnosis secondary and unspecified malignant neoplasm: intrathoracic lymph nodes
5% mortality rate associated with the disease secondary and unspecified malignant neoplasm: intrathoracic lymph nodes
Diagnosis secondary and unspecified malignant neoplasm: intrathoracic lymph nodes is diagnosed Men are 16.88% more likely than Women
465 416
Men receive the diagnosis secondary and unspecified malignant neoplasm: intrathoracic lymph nodes
27 736 (6.0 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
330 973
Women receive the diagnosis secondary and unspecified malignant neoplasm: intrathoracic lymph nodes
10 978 (3.3 %)Died from this diagnosis.
Risk Group for the Disease secondary and unspecified malignant neoplasm: intrathoracic lymph nodes - Men and Women aged 60-64
In Men diagnosis is most often set at age 0-94
Less common in men the disease occurs at Age 0-1, 95+Less common in women the disease occurs at Age 5-14
In Women diagnosis is most often set at age 0-5, 15-95+
Disease Features secondary and unspecified malignant neoplasm: intrathoracic lymph nodes
Absence or low individual and public risk
Secondary and unspecified malignant neoplasm: intrathoracic lymph nodes - what does this mean
Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes is a type of cancer that occurs when cancer cells spread from the primary site of the tumor to the lymph nodes inside the chest cavity. it is usually caused by the spread of cancer from other parts of the body, such as the lungs, breasts, or gastrointestinal tract.
What happens during the disease - secondary and unspecified malignant neoplasm: intrathoracic lymph nodes
Secondary and unspecified malignant neoplasm of the intrathoracic lymph nodes is caused by the spread of cancerous cells from a primary tumor located elsewhere in the body. these cancerous cells travel through the bloodstream or lymphatic system and settle in the intrathoracic lymph nodes, where they grow and spread. as the cancerous cells grow, they can cause the lymph nodes to become enlarged and can interfere with the normal functioning of the lymphatic system.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Comprehensive physical examination
- Chest X-ray
- CT scan of chest and abdomen
- PET scan
- Bronchoscopy
- Thoracoscopy
- Biopsy of the affected lymph nodes
- Flow cytometry
- Immunohistochemistry
- Cytogenetic analysis
Treatment and Medical Assistance
Main Goal: Treating Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
- Surgery to remove the affected lymph nodes
- Chemotherapy
- Radiation therapy
- Immunotherapy
- Targeted therapy
- Clinical trials
- Complementary and alternative medicine
14 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Secondary and unspecified malignant neoplasm: intrathoracic lymph nodes - Prevention
The best way to prevent secondary and unspecified malignant neoplasms of the intrathoracic lymph nodes is to reduce exposure to carcinogens, avoid smoking and excessive alcohol consumption, maintain a healthy diet and lifestyle, and get regular check-ups with your healthcare provider. early detection and treatment of any underlying medical conditions can also help reduce the risk of developing malignant neoplasms of the intrathoracic lymph nodes.